PURPOSE: The purpose was to investigate the risk factors for depressive symptoms in glaucoma patients. METHODS: From the Longitudinal Health Insurance Database in Taiwan, we included 1190 glaucoma patients with subsequent depression diagnoses in the case group and randomly selected 4673 glaucoma patients without depression diagnoses as the control group, matched by age, sex, and time of glaucoma diagnosis. The age-adjusted Charlson comorbidity index (ACCI) score was used to compute the burden of comorbidity for each patient. Current use (past 6 months) of topical antiglaucoma medications and systemic medications was identified. Multivariate regression was used to analyze the risk factors for depression. RESULTS: The mean age for glaucoma patients was 61.88 years. Patients with depressive symptoms had significantly higher ACCI scores (P < .0001). The current use of any topical antiglaucoma medications was not associated with an increased risk for depression. However, higher ACCI scores (P < .0001), cerebrovascular diseases (odds ratio [OR] = 1.324, 95 % confidence interval [CI] = 1.118--1.568), dementia (OR = 2.647, 95 % CI = 2.142-3.270), thyroid diseases (OR = 1.720, 95 % CI = 1.366-2.165), headaches (OR = 1.299, 95 % CI = 1.112-1.518), and current use of systemic β-blockers (OR = 1.782, 95 % CI = 1.538-2.065) and calcium channel blockers (OR = 1.396, 95 % CI, 1.197-1.629) were found to increase the risk of depression in glaucoma patients. CONCLUSIONS: In this study, a comorbidity burden was a significant risk factor for depression in glaucoma patients, particularly for those currently using systemic β-blockers and calcium channel blockers.
PURPOSE: The purpose was to investigate the risk factors for depressive symptoms in glaucomapatients. METHODS: From the Longitudinal Health Insurance Database in Taiwan, we included 1190 glaucomapatients with subsequent depression diagnoses in the case group and randomly selected 4673 glaucomapatients without depression diagnoses as the control group, matched by age, sex, and time of glaucoma diagnosis. The age-adjusted Charlson comorbidity index (ACCI) score was used to compute the burden of comorbidity for each patient. Current use (past 6 months) of topical antiglaucoma medications and systemic medications was identified. Multivariate regression was used to analyze the risk factors for depression. RESULTS: The mean age for glaucomapatients was 61.88 years. Patients with depressive symptoms had significantly higher ACCI scores (P < .0001). The current use of any topical antiglaucoma medications was not associated with an increased risk for depression. However, higher ACCI scores (P < .0001), cerebrovascular diseases (odds ratio [OR] = 1.324, 95 % confidence interval [CI] = 1.118--1.568), dementia (OR = 2.647, 95 % CI = 2.142-3.270), thyroid diseases (OR = 1.720, 95 % CI = 1.366-2.165), headaches (OR = 1.299, 95 % CI = 1.112-1.518), and current use of systemic β-blockers (OR = 1.782, 95 % CI = 1.538-2.065) and calcium channel blockers (OR = 1.396, 95 % CI, 1.197-1.629) were found to increase the risk of depression in glaucomapatients. CONCLUSIONS: In this study, a comorbidity burden was a significant risk factor for depression in glaucomapatients, particularly for those currently using systemic β-blockers and calcium channel blockers.
Authors: Louis R Pasquale; Jae Hee Kang; JoAnn E Manson; Walter C Willett; Bernard A Rosner; Susan E Hankinson Journal: Ophthalmology Date: 2006-06-06 Impact factor: 12.079
Authors: M Roy Wilson; Anne L Coleman; Fei Yu; Irene Fong Sasaki; Eric G Bing; Matthew H Kim Journal: Ophthalmology Date: 2002-05 Impact factor: 12.079
Authors: Jeffrey M Lyness; Moonseong Heo; Catherine J Datto; Thomas R Ten Have; Ira R Katz; Rebecca Drayer; Charles F Reynolds; George S Alexopoulos; Martha L Bruce Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: Vikas Chopra; Rohit Varma; Brian A Francis; Joanne Wu; Mina Torres; Stanley P Azen Journal: Ophthalmology Date: 2007-08-22 Impact factor: 12.079
Authors: Alberto Diniz-Filho; Ricardo Y Abe; Hyong Jin Cho; Saif Baig; Carolina P B Gracitelli; Felipe A Medeiros Journal: Ophthalmology Date: 2016-02-23 Impact factor: 12.079
Authors: J Rezapour; S Nickels; A K Schuster; M Michal; T Münzel; P S Wild; I Schmidtmann; K Lackner; A Schulz; N Pfeiffer; M E Beutel Journal: BMC Ophthalmol Date: 2018-06-28 Impact factor: 2.209